Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 231

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Standardized, unrelated donor cord blood transplantation in adults with hematologic malignancies

Sanz, Guillermo F., Saavedra, Silvana, Planelles, Dolores, Senent, Leonor, Cervera, Jose, Barragán, Eva, Jiménez, Carmen, Larrea, Luis, Martı́n, Guillermo, Martı́nez, Jesús, Jarque, Isidro, Moscardó, Federico, Plumé, Gemma, Andreu, Rafael, Regadera, Ana I., Garcı́a, Inmaculada, Mollá, Susana, Solves, Pilar, de la Rubia, Javier, Bolufer, Pascual, Benlloch, Luis, Soler, Marı́a A., Marty, Marı́a L., Sanz, Miguel A. · 2001 · Blood

Abstract

The potential role of unrelated donor cord blood transplantation (UD-CBT) in adults remains unclear. This study reports the results of UD-CBT in 22 adults with hematologic malignancies following conditioning with thiotepa, busulfan, cyclophosphamide, and antithymocyte globulin in 21, with thiotepa, fludarabine, and antithymocyte globulin in 1, and graft-versus-host disease (GVHD) prophylaxis with cyclosporine and prednisone. Median age was 29 years (range, 18-46 years), and median weight was 69.5 kg (range, 41-85 kg). HLA match was 6 of 6 in 1 case, 5 of 6 in 13 cases, and 4 of 6 in 8 cases. Median number of nucleated cells infused was 1.71 × 107/kg (range, 1.01 × 107/kg to 4.96 × 107/kg). All 20 patients surviving more than 30 days had myeloid engraftment, and only 1, who received the lowest cell dose, developed secondary graft failure. Median time to reach an absolute neutrophil count of at least 0.5 × 109/L was 22 days (range, 13-52 days). Median time to platelets numbered at least 20 × 109/L was 69 days (range, 49-153 days). Seven patients (32%) developed acute GVHD above grade II, and 9 of 10 patients at risk developed chronic GVHD, which became extensive in 4 patients. Twelve patients remained alive and disease-free 3 to 45 months after transplantation. Disease-free survival (DFS) at 1 year was 53%. Age strongly influenced DFS (P = .01). For patients aged 30 years or younger, the DFS at 1 year was 73%. These preliminary results suggest that UD-CBT should be considered a reasonable alternative in young adults with hematologic malignancy and no appropriate bone marrow donor.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1182/blood.v98.8.2332

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 231

Metadata

Authors
Sanz, G. F., Saavedra, S., Planelles, D., Senent, L., Cervera, J., Barragán, E., Jiménez, C., Larrea, L., Martı́n, G., Martı́nez, J., Jarque, I., Moscardó, F., Plumé, G., Andreu, R., Regadera, A. I., Garcı́a, I., Mollá, S., Solves, P., de la Rubia, J., Bolufer, P., Benlloch, L., Soler, M. A., Marty, M. L., & Sanz, M. A.
Venue
Blood
Published
2001-10-15
Volume
98
Issue
8
Pages
2332-2338
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W2101134081
Cited by
231
References
1
FWCI
7.83
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Standardized, unrelated donor cord blood transplantation in adults with hematologic malignancies. https://app.cochat.ai/papers/10.1182/blood.v98.8.2332
The paper
Sanz, G. F., Saavedra, S., Planelles, D., Senent, L., Cervera, J., Barragán, E., Jiménez, C., Larrea, L., Martı́n, G., Martı́nez, J., Jarque, I., Moscardó, F., Plumé, G., Andreu, R., Regadera, A. I., Garcı́a, I., Mollá, S., Solves, P., de la Rubia, J., . . . Sanz, M. A. (2001). Standardized, unrelated donor cord blood transplantation in adults with hematologic malignancies. Blood. https://doi.org/10.1182/blood.v98.8.2332

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.